Answers are grounded in this paper and cite their sources.
Review analyzes clinical benefits and limitations of bioimpedance analysis in chronic kidney disease and heart failure, suggesting future directions.
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its clinical application is still not fully widespread. The aim of this review is to provide a comprehensive overview of the state of the art of BIA utilization by analyzing the clinical benefits, limitations, and potential future developments in this clinically unexplored field.
No takes yet. Share an insight, caveat, or question.
Porta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: